Serum creatine kinase levels associated with benign paroxysmal vertigo in childhood

July 1, 2005

Serum creatine kinase levels associated with benign paroxysmal vertigo in childhood.

The serum level of creatine kinase-MB (CK-MB) was elevated in 22 children with benign positional vertigo (BPV) evaluated prospectively by investigators and followed for, on average, 2.8 years. CK-MB values were unrelated to duration of BPV, time since last attack, and frequency of attack. In seven children who recovered from BPV during the study period, the CK-MB level normalized (Rodoo P et al: J Pediatr 2005;146:548).